This announcement is a separate document:
再鼎醫藥：內幕消息 - 衛偉迦（艾加莫德）被納入國家醫保藥品目錄
ZAI LAB: INSIDE INFORMATION - THE INCLUSION OF VYVGART (EFGARTIGIMOD ALFA INJECTION) IN CHINA''S NATIONAL REIMBURSEMENT DRUG LIST
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.